$NVNO News

enVVeno Medical Q2 EPS $(5.37) Up From $(11.55) YoY

EnVVeno Medical Issued U.S. Patent For Its Intellectual Property Portfolio Supporting Its enVVe Transcatheter Replacement Venous Valve System To Treat Venous Disease

enVVeno Medical to Participate in the Virtual Investor Closing Bell Series

enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment

enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System

enVVeno Medical Q1 EPS $(5.89) Misses $(0.28) Estimate

One enVVeno Medical Insider Raised Their Stake In The Previous Year

enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve

enVVeno Medical Receives FDA IDE Approval To Proceed With U.S. Pivotal Study Of Non-Surgical Replacement Venous Valve

enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System

enVVeno Medical Q4 EPS $(6.05) Misses $(0.30) Estimate

NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives

enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

enVVeno Medical Corporation Announces Nasdaq Compliance Regained With Minimum $1.00 Closing Bid Price For 10 Days

12 Health Care Stocks Moving In Monday's Pre-Market Session

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

enVVeno Medical shares are trading lower after the company announced a 1-for-35 reverse stock split.

enVVeno Medical Announces Reverse Stock Split

enVVeno Medical Board Approves Reverse Stock Split Of Common Shares At Ratio Of 1 For 35